Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PSA density (PSAD). Role in patient evaluation and management.

Literature DB >> 7505973

PSA density (PSAD). Role in patient evaluation and management.

E Seaman¹, M Whang, C A Olsson, A Katz, W H Cooner, M C Benson.

Abstract

Prostate Specific Antigen (PSA) is the most accurate serum marker for cancer of the prostate. However, sensitivity and specificity are suboptimal, especially at the intermediate levels between 4.1 and 10.0 ng/ml (monoclonal). For intermediate PSA levels, prostate specific antigen density (PSAD) provides unique information regarding the need for biopsy and the likelihood of prostate cancer. This article summarizes the utility of PSAD in diagnosing and treating prostate cancer.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1993 PMID： 7505973

Source DB: PubMed Journal: Urol Clin North Am ISSN： 0094-0143 Impact factor: 2.241

Keyword Cloud
Cited

12 in total

Review 1. The role of prostate specific antigen in screening and management of clinically localized prostate cancer.

Authors: Khurshid Guru; Ashutosh Tewari; Ashok K Hemal; John Wei; Javid Javidan; James Peabody; Mani Menon
Journal: Int Urol Nephrol Date: 2003 Impact factor: 2.370

Review 2. The safety of testosterone supplementation therapy in prostate cancer.

Authors: James M Dupree; Gavin M Langille; Mohit Khera; Larry I Lipshultz
Journal: Nat Rev Urol Date: 2014-07-29 Impact factor: 14.432

Review 3. Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.

Authors: Ananthakrishnan Sivaraman; Kulthe Ramesh Seetharam Bhat
Journal: Indian J Surg Oncol Date: 2017-01-23

4. Prostate-specific antigen density: the role in benign prostate hyperplasia, prostate intraepithelial neoplasm, organ-confined prostate carcinoma and advanced prostate carcinoma.

Authors: L Işikay; M Bozlu; Y Z Müftüğlu; O Göğüş
Journal: Int Urol Nephrol Date: 1995 Impact factor: 2.370

Review 5. ABC of urology. Bladder outflow obstruction.

Authors: C Dawson; H Whitfield
Journal: BMJ Date: 1996-03-23

6. The role of empiric antibiotic treatment in preventing unnecessary prostate biopsies in asymptomatic patients with PSA levels between 4 and 10 ng/ml.

Authors: Ali Saribacak; Hasan Yilmaz; Seyfettin Ciftci; Murat Ustuner; Levend Ozkan; Tayyar Alp Ozkan; Ozdal Dillioglugil
Journal: Int J Clin Exp Med Date: 2014-08-15

PSA density (PSAD). Role in patient evaluation and management.

Review 1. The role of prostate specific antigen in screening and management of clinically localized prostate cancer.

Review 2. The safety of testosterone supplementation therapy in prostate cancer.

Review 3. Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective.

4. Prostate-specific antigen density: the role in benign prostate hyperplasia, prostate intraepithelial neoplasm, organ-confined prostate carcinoma and advanced prostate carcinoma.

Review 5. ABC of urology. Bladder outflow obstruction.

6. The role of empiric antibiotic treatment in preventing unnecessary prostate biopsies in asymptomatic patients with PSA levels between 4 and 10 ng/ml.

Review 7. Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate.

8. Serum PSA and age-specific reference ranges in patients with prostatism symptoms.

Review 9. [Early detection of prostate cancer: is serum PSA testing alone sufficient?].

10. Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?